Cell Cycle, Apoptosis, Cancer Flashcards
in interphase, what happens at G1, S, and G2
G1: RNA and protein synthesis needed for DNA replication
S: DNA synthesis
G2: DNA stability is checked
G0 phase
In poor nutrient/environmental conditions, cells withdraw from the cell cycle
Also occurs following terminal differentiation in certain tissue types (brain, neurons, cardiac muscle, RBCs)
When is histone synthesis and centrosome formation
During S phase
Where is the one restriction point and three checkpoints in the cell cycle
Restriction point at the end of G1 two hours before S phase
- G1 checkpoint
- G2 checkpoint
- Metaphase checkpoint in M phase
How do growth factors affect the cell cycle
If growth factors are limiting then restriction occurs
Progression following the exit from restriction is growth factor independent
When does G1 checkpoint occur
At end of G1 phase in response to DNA damage
What is the purpose of the G2 checkpoint
To verify complete genomic duplication
What is the purpose of the metaphase checkpoint
Ensures that chromosomes are attached to the mitotic spindle
Mutations in Aurora B and BUB1 in spindle assembly cause
Colorectal, lung, and pancreatic tumors and T cell lymphomas
Mutations in BUB1B, BUB3 and MPS1 in spindle assembly cause
Colorectal cancer, lymphomas, MVA and PC55
Mutations in ATM during chromosome condensation cause
Lymphomas and breast cancer
ATR mutations in chromosome condensation cause
Stomach, endometrial, and breast cancer
CHK1 mutations in chromosome condensation cause
Stomach, endometrial, colorectal, and lung cancers
CDK1 and PLK1 mutations in centrosome duplications cause
Cancers of the liver, lung, stomach, and epidermis
Aurora A mutations in centrosome duplication cause
Several human tumors, for example, breast and colorectal cancers
CDK4 mutations in G0 phase cause
Melanoma, gliobastoma, osteosarcoma, and breast and Cervical cancers
CDK6 mutations in RB inactivation cause
Lymphomas, squamous cell cancer, and gloom a
CHK2 mutations before DNA replication in G1 cause
Bladder, colon, ovary, and other cancers
Myc
- what is it
- how does it regulate cellular division
Transcription factor
Increases CDK levels in G1 —> which phosphorylates Rb —> which releases E2F allowing cell to enter S phase
How do cyclins affect cell division
Cyclin D-CDK4
Cyclin D-CDK6
Hyperphosphorylate Rb which releases E2F —> cell enters S phase
How does E2F allow the cell to enter and stay in the S phase
E2F has transcription genes for Cyclin E (so that the cell can transition to S phase) and Cyclin A (to keep Rb in hyperphosphorylated state)
Both Cyclin E and A activate CDK2 which maintains the hyperphosphorylation of Rb
Cyclins
Proteins that interact with and regulate CDK activity
How is cyclin-CDK activity inhibited
P27 and WEE1 inhibit the cyclin-CDK complex by inactivating the kinase activity of cyclin-CDK
CAK
CDK-activating kinase
Fully activates the cycle-CDK complex by phosphorylating the T loop that blocks the active site of the complex
G1 cyclin (D)
- function
- Cyclin-DKA complex(es)
Helps the passage of cells through the restriction point in late G1 phase
Cyclin D-CDK4
Cyclin D-CDK6
WEE1 kinase
Inhibits CDK activity by phosphorylating the “roof site”
Cdc25
Dephosphorylates “roof site” to increase CDK activity
P27
A type of CDK inhibitory protein (CKI)
Binds to both CDK and cyclin; primarily regulates early in cell cycle events (like G1 —> S)
APC/C
Anaphase promoting complex (also called cyclosome)
Key regulator in progression from metaphase to anaphase
Activated by binding to Cdc20
—> polyubiquinates its substrates (including S- and M- cyclin complexes)
—> cyclins targeted for destruction
—> absence of cyclins inactivates CDK
Cdc20
Activates APC/C
P53
Guardian of the genome
Normally kept inactive by E3 ubiquitin ligase (MDM2)
Stimulated by DNA damage and activated by phosphorylation
—> increase in p21 (a CKI)
—> cell cycle arrest
P21
A cyclin-dependent kinase inhibitor (CKI)
Active p53 causes transcription of the gene p21 which leads to inactivation of cyclin-CDK complexes for G1/S transition (CDK2); this keeps RB hypophosphorylated and active which sequesters E2F
Capable of inhibiting all cyclin/CDK complexes, but primarily associated with inhibition of CDK2
MDM2
Keeps p53 inactive in normal state
An E3 ubiquitin ligase
Internal stimuli for apoptosis pathways
Abnormalities in DNA
External stimuli for apoptosis pathways
Removal or survival factors
Proteins of tumor necrosis factor family (TNF-a)
Intrinsic pathway of apoptosis
Mitochondrial dependent (cytochrome C is leaked from the mitochondria)
Activates apoptosome formation —> procaspase-9 (inactive) —> caspace-9 (active) —> caspaces-3,6,7 —> apoptosis —> phagocytosis
Extrinsic pathway for apoptosis
Fas ligand binds to Fas receptor of membrane
—> procaspase-8
—> rest of cycle
TNF-a binds to TNF-a receptor on membrane
—> caspase-8
—> caspases-3,6,7
—> apoptosis
BAX/BCL-2
Key regulator in intrinsic apoptosis pathway
Initiator caspases
Caspase-8
Caspase-9
Executioner caspase
Caspase-3
Executes apoptosis
Apaf1 in the intrinsic pathway of apoptosis
Activated by the release of cytochrome C from the mitochondria
Activates BAX
Forms the apoptosome
Cytochrome c/Apaf1 complex activates caspase-9
Proto-oncogene
Growth factors Receptors for growth factors and hormones Transcription factors Signal transducers ^normally promotes cell cycle
Gain of function mutations —> oncogene
Oncogenes
Increase expression of protein products
Express altered proteins (oncoproteins) that do not respond to normal signals
How do oncogenes cause breast cancer
HER2 receptor has a valine to glutamine mutation
Receptors dimerize and tyrosine kinase activity activated in absence of ligand (over-expression of HER2) causing breast cancer
How do oncogenes cause glioblastoma
EGF receptor has a deletion mutation and the receptor’s tyrosine kinase activity is constitutively active causing gliobastoma
How do oncogenes cause chronic myelogenous leukemia (CML)
Translocation between chromosome 9 and 22 producing BCR-ABL gene, which expresses the BCR-ABL fusion protein causing CML
Retinoblastoma (Rb)
Tumor suppressor
Remains hypophosphorylated and sequesters E2F, blocking G1/S transition
When it is hyperphosphorylated by cyclin D-CDK4 and cyclin D-CDK6 it becomes inactive and released E2F which will then transition the cell to the S phase
How is retinoblastoma (the phenotype) caused
Mutation/deletion of both copies of RB1 is needed to cause cancer (“two-hit hypothesis”)
Somatic mutation occurs and eliminates the second good copy of the gene which causes tumors form in highly proliferative tissues
Sporadic form of retinoblastoma
Non hereditary
Abnormality in the RB1 gene develops on its own in only one cell in one eye
Found at a later age than hereditary retinoblastoma
RB1 gene
- what does it do
- what do mutations cause
- where is the mutation
Encodes pRb (Rb) protein
Mutations cause 100% of retinoblastoma
Chromosome 13 (regulates G1 phase of cell cycle)
TP53
- what does it do
- what do mutations cause
Encodes p53
Mutations cause:
- 65% colon cancers
- 30%-50% breast cancers
- 50% lung cancers
PTEN (phosphate and tensin homolog)
- what do mutations cause
70% of prostate cancers
APC (adenomatous polyposis coli)
- what do mutations cause
- where is the mutation
Colon cancer (family adenomatous polyposis)
Mutation is in chromosome 5 which regulates cell proliferation
What do metastasis suppressors do
They’re cell adhesion proteins
- prevent tumor cells from dispersing
- block loss of contact inhibition
- inhibit tumor metastasis
NF-1 gene
- where is it located
- what does it normally do
- what does the mutated product do
Chromosome 17
Encodes p120GAP which normally turns off activated RAS protein
Causes neurofibromatosis
BRCA1/BRCA2 gene
- where is it located
- what is its normal function
- mutated product does what
Chromosome 17
Role in DNA repair and apoptosis
Breast cancer
DCC gene
- where is it
- what does it normally do
- mutated form does what
Chromosome 18
Role in cell proliferation, migration, and apoptosis
Colon cancer
6 hallmarks of cancer
- Ability to grow along (oncogenes)
- Tumor suppressor failure
- Invading and metastasis
- Telomerase up-activation
- Angiogenesis
- Resisting cell death from apoptosis
4 gene alterations than can lead to metastasis
- loss of APC
- activation of RAS
- loss of a tumor suppressor gene
- loss of p53 gene
How can viruses cause cancer
- normal virus infects host
- viral genome incorporates into host genome next to proto-oncogene
- virus replications containing proto-oncogene
- proto-oncogene mutates into oncogene
- virus containing oncogene infects normal cell transforming it into a tumor cell
How does HPV cause cancer
- E6+ binds to p53
- degrades p53 and loses tumor suppression
Or
- E7 binds to RB
- Rb becomes inactive and releases E2F
Epstein Barr Virus is associated with what tumors
Burkitt lymphoma
Nasopharyngeal carcinoma
Hepatitis B virus is associated with what tumors
Liver cancer (hepatocellular carcinoma)
HPV is associated with what tumors
Benign warts
Cervical and uterine cancers
Human T Cell leukemia virus type 1 (HTLV-1) is associated with what cancer
Adult T cell leukemia/lymphoma
Kaposi sarcoma-associates herpesvirus (KSHV) is associated with what cancer
Kaposi sarcoma
How to alkylating agents act as chemotherapeutic agents
Block dna replication
How do antimetabolites act as chemotherapeutic agents
Inhibit enzymes involved in dna synthesis
How do topoisomerase I inhibitors act as chemotherapeutic agents
Inhibit topoisomerase I, an enzyme that removes supercoils in dna
How to topoisomerase II inhibitors act as chemotherapeutic agents
Inhibit topoisomerase II, an enzyme that resolves tangles in DNA
How to cytotoxic antibiotics act as chemotherapeutic agents
Intercalated between bases in dna to inhibit dna synthesis
How do mitotic inhibitors act as chemotherapeutic agents
Arrest cells in mitosis during metaphase
Ifosfamide Cyclophosphamide Treosulfane Carboplatin Cisplatin
Alkylating agents
Chemotherapy
Cytarabine 5-fluorouracil Gemcitaine Mercaptopurine Methotrexate
Antimetabolites
chemotherapy
Etoposide
Teniposide
Topoisomerase I inhibitors
Chemotherapy
Topotecan
Topoisomerase II inhibitor
Chemotherapy
Daunorubicin
Doxorubicin
Epiruicin
Mitoxantrone
Cytotoxic antibiotics
Chemotherapy
Docetaxel Paclitaxel Vinblastine Vincristine Vindesine Vinorelbine
Mitotic inhibitors
Chemotherapy
Herceptin
Trastuzumab
Chemotherapy drug
- Blocks cleavage
- Blocks dimerization
- Activates antibody-dependent cell-mediated cytotoxicity that leads to tumor cell lysis
Gleevec
Imatinib Mesylate
Chemotherapy drug
Blocks ATP from binding to Bcr/c-Abl enzyme and prevent chronic myelogenous leukemia
Erbitux
Cetuximab
Chemotherapy drug
Blocks ligand binding to EGFR and prevents activation of signal transduction cascades (MAPK) leading to cancer